Study evaluates four-drug TB treatment for HIV/AIDS patients

Post Date: 
Vaccine News Daily

"Our results even suggest the four-drug strategy is actually doing more harm than isoniazid-alone therapy because study participants found it less tolerable and stopped using it," Dr. Amita Gupta, senior study author and associate professor of medicine and deputy director of the Johns Hopkins Center for Clinical Global Health Education, said.